Inventor · disambiguated record
David Liu
Also filed as: LIU DAVID · LIU DAVID LEXIN
41 granted patents·18 pending applications·326 citations·filing 2012–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US11033634B2Light chain variable regionsABBVIE STEMCENTRX LLC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0297US9089615B2Anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·21 cites·30 claims
- 0397US8986972B2Nucleic acid encoding DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Mar 24, 2015·22 cites·30 claims
- 0496US9937268B2Anti-DLL3 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 10, 2018·9 cites·30 claims
- 0596US9931421B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0696US9931420B2Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Apr 3, 2018·9 cites·30 claims
- 0796US9878053B2Methods of delivering DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 30, 2018·9 cites·30 claims
- 0896US9867887B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 16, 2018·9 cites·30 claims
- 0996US9861708B2Kits containing DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 9, 2018·9 cites·30 claims
- 1096US9855343B2Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 2, 2018·9 cites·30 claims
- 1196US9775916B1Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2017·Granted Oct 3, 2017·9 cites·30 claims
- 1296US9770518B1Anti-DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 26, 2017·9 cites·30 claims
- 1396US9764042B1Methods of making DLL3 antibody drug conjugatesABBVIE STEMCENTRX LLC·Filed 2017·Granted Sep 19, 2017·9 cites·30 claims
- 1496US9358304B1Methods of making DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Jun 7, 2016·10 cites·30 claims
- 1596US9352051B1Kits containing DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 31, 2016·10 cites·30 claims
- 1696US9353182B2Anti-DLL3 antibodiesSTEMCENTRX INC·Filed 2015·Granted May 31, 2016·10 cites·21 claims
- 1796US9334318B1Multivalent DLL3 antibodiesSTEMCENTRX INC·Filed 2016·Granted May 10, 2016·11 cites·28 claims
- 1896US9155803B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Oct 13, 2015·10 cites·30 claims
- 1996US9133271B1Anti-DLL3 antibody drug conjugates and methods of useSTEMCENTRX INC·Filed 2015·Granted Sep 15, 2015·10 cites·30 claims
- 2096US9089617B2Anti-DLL3 antibody drug conjugatesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·13 cites·30 claims
- 2195US10137204B2Anti-DLL3 antibody drug conjugates for treating cancerABBVIE STEMCENTRX LLC·Filed 2016·Granted Nov 27, 2018·8 cites·33 claims
- 2295US9486537B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 8, 2016·9 cites·22 claims
- 2395US9480757B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·9 cites·29 claims
- 2495US9107961B2Anti-DLL3 antibody drug conjugates for treating cancerSTEM CENTRX INC·Filed 2014·Granted Aug 18, 2015·11 cites·30 claims
- 2595US9089616B2Anti-DLL3 antibody drug conjugates and methods of useSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2694US9090683B2Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodiesSTEM CENTRX INC·Filed 2014·Granted Jul 28, 2015·10 cites·30 claims
- 2790US9534058B2Anti-CD324 monoclonal antibodies and uses thereofSTEM CENTRX INC·Filed 2013·Granted Jan 3, 2017·10 cites·10 claims
- 2890US9345784B1Methods of delivering DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted May 24, 2016·3 cites·30 claims
- 2989US9676850B2Anti SEZ6 antibodies and methods of useSTEM CENTRX INC·Filed 2013·Granted Jun 13, 2017·10 cites·12 claims
- 3089US9173959B1Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2015·Granted Nov 3, 2015·3 cites·30 claims
- 3188US9481727B2Anti-DLL3 antibody drug conjugatesSTEMCENTRX INC·Filed 2016·Granted Nov 1, 2016·2 cites·26 claims
- 3285US10035853B2Site-specific antibody conjugation methods and compositionsABBVIE STEMCENTRX LLC·Filed 2016·Granted Jul 31, 2018·13 cites·42 claims
- 3380US10053511B2Anti-claudin antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2014·Granted Aug 21, 2018·5 cites·55 claims
- 3480US9993566B2SEZ6 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2014·Granted Jun 12, 2018·4 cites·41 claims
- 3578US10047163B2Multispecific constructsABBVIE STEMCENTRX LLC·Filed 2014·Granted Aug 14, 2018·3 cites·3 claims
- 3677US10533051B2Anti SEZ6 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2017·Granted Jan 14, 2020·1 cites·17 claims
- 3777US2019247510A1Dll3 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2019·Application pending·0 cites
- 3875US2019046656A1Dll3 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
- 3972US2025213714A1Anti-sez6 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2025·Application pending·0 cites
- 4071US10189910B2Anti-DPEP3 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Jan 29, 2019·1 cites·38 claims
- 4171US9777071B2Anti-DPEP3 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2016·Granted Oct 3, 2017·1 cites·15 claims
- 4269US2021338831A1Anti-sez6 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2021·Application pending·0 cites
- 4368US11077203B2Anti-SEZ6 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2020·Granted Aug 3, 2021·0 cites·4 claims
- 4468US2021196834A1Anti-sez6 antibody drug conjugates and methods of useABBVIE STEMCENTRX LLC·Filed 2019·Application pending·0 cites
- 4567US2020181256A1Anti sez6 antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2019·Application pending·0 cites
- 4650US10087258B2Anti-CD324 monoclonal antibodies and uses thereofABBVIE STEMCENTRX LLC·Filed 2016·Granted Oct 2, 2018·0 cites·8 claims
- 4749US2019077876A1Novel anti-claudin antibodies and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
- 4849US2019022241A1Novel sez6 modulators and methods of useABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
- 4945US9962403B2Formulation drug of sodium ion and calcium ion for treating cancer, tumor and nonmalignancyLIU DAVID LEXIN·Filed 2012·Granted May 8, 2018·0 cites·6 claims
- 5043US2018346565A1Site-specific antibody conjugation methods and compositionsABBVIE STEMCENTRX LLC·Filed 2018·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →